Migraine with Aura Diagnosis
Diagnose migraine with aura when a patient has experienced at least 2 attacks of fully reversible neurological symptoms (visual, sensory, or speech disturbances) that develop gradually over ≥5 minutes, last 5-60 minutes, and are followed by headache within 60 minutes. 1
Diagnostic Criteria
The International Headache Society requires all of the following for formal diagnosis 2, 1:
Minimum Attack Frequency:
Aura Symptom Types (one or more must be present):
- Visual disturbances (most common—scintillations, scotomas, zigzag lines) 1, 3
- Sensory symptoms (hemisensory disturbances, pins and needles, numbness) 1
- Speech/language problems (aphasia, typically Broca-type) 1, 4
- Motor symptoms (weakness, as in hemiplegic migraine) 1
- Brainstem symptoms (dysarthria, vertigo) 1
- Retinal symptoms (monocular visual loss) 1
Required Temporal Characteristics (at least 3 of 6):
- At least one aura symptom spreads gradually over ≥5 minutes 2, 1
- Two or more aura symptoms occur in succession 2, 1
- Each individual aura symptom lasts 5-60 minutes 2, 1
- At least one aura symptom is unilateral 2
- At least one aura symptom is positive (scintillations, pins and needles) 2
- The aura is accompanied or followed within 60 minutes by headache 2, 1
Exclusion Requirement:
- Not better accounted for by another diagnosis 2
Critical Distinguishing Features
Gradual onset over ≥5 minutes is the key differentiator from stroke/TIA, which presents with sudden simultaneous onset. 5, 1 This temporal pattern is essential for diagnosis and helps avoid misdiagnosis of cerebrovascular events.
Visual aura specifics:
- Binocular visual phenomena affecting both visual fields simultaneously distinguishes typical migraine with aura from retinal migraine 5
- Retinal migraine causes monocular visual disturbances (one eye only, confirmed by covering the unaffected eye) 5
- Both conditions require repeated attacks, not single episodes 5
Red Flags Requiring Urgent Evaluation
Do not diagnose migraine with aura if any of the following are present—these require immediate neuroimaging with MRI: 1
- Prolonged aura >60 minutes (suggests stroke, AVM, or structural lesion) 1
- Sudden, simultaneous onset of all symptoms (suggests TIA rather than migraine) 1
- First-time aura in patient >50 years old
- Aura without subsequent headache in a patient without prior migraine history
- Motor weakness (requires exclusion of stroke before diagnosis)
Differential Diagnosis Considerations
Epileptic aura vs. migraine aura:
- Epileptic auras typically last seconds to 2 minutes, whereas migraine auras last 5-60 minutes 6
- Epileptic visual phenomena may include elementary hallucinations (flashing lights) but lack the gradual spread characteristic of migraine 6
- Epigastric rising sensation is more characteristic of temporal lobe epilepsy than migraine 6
Clinical Pitfalls
Aura may be underrecognized because patients often don't report non-visual symptoms unless specifically asked. 7 Proactively inquire about sensory changes, speech difficulties, and other neurological symptoms beyond visual disturbances, as prevalence is much higher in individuals with professional knowledge of aura manifestations. 7
Migraine with aura may present without headache in some attacks, particularly in older patients or those with long-standing migraine history. 3 However, the diagnostic criteria still require headache to follow within 60 minutes for formal diagnosis. 2
Monocular visual symptoms require urgent ophthalmologic consultation and aggressive prophylaxis, not just symptomatic treatment, given vision loss risk. 5
Comorbidity Considerations for This Patient Population
Young to middle-aged females with family history of migraine and comorbid depression/anxiety represent a typical migraine with aura demographic. 3, 8 The genetic susceptibility is higher for migraine with aura compared to migraine without aura, though specific variants remain incompletely characterized outside of rare familial hemiplegic migraine forms. 8
Depression and anxiety are common comorbidities that do not exclude the diagnosis but may complicate treatment selection. 9 Consider serotonin syndrome risk when combining triptans with SSRIs, SNRIs, TCAs, or MAO inhibitors—symptoms include mental status changes, autonomic instability, and neuromuscular aberrations. 10
Pathophysiology Context
Cortical spreading depression (CSD) is the underlying phenomenon for migraine aura, supported by animal models and functional neuroimaging. 3, 9 This manifests as transient hypoperfusion not restricted to vascular territories, sometimes with dilated veins visible on susceptibility-weighted MRI ("index vein" sign). 9 EEG during typical visual aura shows no consistent abnormalities, though transient focal occipital slowing may occur. 9